Congress: To prevent addiction, empower physicians and patients to choose non-opioids

Each thirty day period, it seems, the United States smashes yet another unenviable history when it comes to drug habit and overdose studies. According to the Centers for Disorder Control…

Trial of EDG-5506, Becker MD Treatment, Begins Enrolling Patients | Oral Therapy Aims to Preserve Muscle Health

A Phase 2 scientific demo testing Edgewise Therapeutics’ investigational oral therapy EDG-5506 is recruiting boys and adult males with Becker muscular dystrophy (BMD). Identified as CANYON (NCT05291091), the review plans…